期刊文献+

c-FLIP-L影响乳腺癌MDA-MB-231细胞对TRAIL致凋亡作用的敏感性 被引量:1

Effect of c-FLIP-L on the sensitivity of breast cancer MDA-MB-231 cells to TRAIL-induced apoptosis
下载PDF
导出
摘要 目的:观察c-FLIP-L对TRAIL诱导乳腺癌MDA-MB-231细胞凋亡的影响及其具体机制。方法:构建靶向c-FLIP-L的siRNA质粒,转染乳腺癌MDA-MB-231细胞,RT-PCR、Weston blotting验证基因抑制效果。实验分空白对照组、TRAIL组、c-FLIP-L siRNA组和c-FLIP-L siRNA+TRAIL组共4组,MTT法检测各组MDA-MB-231细胞的增殖情况,流式细胞术检测MDA-MB-231细胞凋亡率,Transwell实验检测MDA-MB-231细胞侵袭能力,RT-PCR、Western blotting检测MDA-MB-231细胞中c-FLIP-L、caspase-3、caspase-8、MMP-2、MMP-9的表达。结果:靶向c-FLIP-L的siRNA质粒转染至乳腺癌细胞株可有效抑制c-FLIP-L mRNA[(37.12±3.02)vs(183.21±8.31),(174.65±10.06);P<0.05]及其蛋白的水平。c-FLIP-L siRNA和TRAIL联合处理MDA-MB-231细胞,与两者单独处理相比,细胞增殖抑制率显著升高[72 h时,(75.51±2.01)%vs(33.75±1.60)%,(34.31±2.01)%;均P<0.05],凋亡率显著升高[72 h时,(76.30±4.11)%vs(38.95±2.14)%,(29.28±1.66)%;均P<0.05],对细胞侵袭能力的抑制也显著增强。c-FLIP-L siRNA和TRAIL联合处理后,与两者单独处理相比,乳腺癌细胞中casepase-3、casepase-8的表达显著增强,而MMP-2、MMP-9的表达明显减弱。结论:抑制c-FLIP-L表达能够增强MDA-MB-231细胞对TRAIL的敏感性,从而提高诱导肿瘤细胞凋亡的能力,其机制可能与caspase-3、caspase-8的表达上调和MMP-2、MMP-9的表达下调有关。 Objective : To study the effect of c-FLIP-L on TRAIL-induced breast cancer apoptosis. Methods: c-FLIP-L was silenced in breast cancer MDA-MB-231 cells by siRNA. After c-FLIP-L silencing, cell proliferation was assessed by MTT assay, cell apoptosis by Annexin-V FITC/PI double staining flow cytometry, invasive potential by matrigel invasion assay, and protein and mRNA levels of c-FLIP-L, caspase-3, caspase-8, MMP-2, MMP-9 in transfected cells by Western blotting and RT-PCR respectively. Results: The sequence-specific siRNA significantly decreased c-FLIP-L mRNA (3712±3.02 vs 183.21±8.31, 174.65±10.06; P 〈0.05) and protein levels as compared with the control. At 72 h after treatment, c-FLIP-L siRNA and TRAIL, either in combination or each alone, significantly inhibited proliferation ([75.51±2.01]% vs [33.75±1.60]%, [34.31±2.01]%; P 〈0.01), induced apoptosis ([76.30±4.11]% vs [38.95±2.14]%, [29.28±1.66]%; P 〈0.05), decreased the invasive capacity. Enhanced casepase-3 and casepase-8 expression,and inhibited MMP-2 and MMP-9 expression in MDA-MB-231 cells. Conclusion: Inhibition of c-FLIP-L expression may increase the sensitivity of breast cancer cells to TRAIL-induced apoptosis, possibly through enhancing the expression of caspase-3, caspase-8 and inhibiting the expression of MMP-2 and MMP-9.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2014年第1期31-37,共7页 Chinese Journal of Cancer Biotherapy
基金 辽宁省自然科学基金资助项目(No.2013022051)~~
关键词 乳腺癌 MDA-MB-231细胞 TRAIL c-FLIP-L 凋亡 breast cancer MDA-MB-231 cell TRAIL c-FLIP-L apoptosis
  • 相关文献

参考文献22

  • 1Sbaine W,Holger K,Day TW. Apoptosis:Targets in pancreatie cancer[J].Molecular Cancer Therapautics,2003,(01):6-20.
  • 2Kim YS,Jin HO,Seo SK. Sorafenib induces apoptotic cell death in human non-small cell lung cancer cells by down-regulatingmammalian target of rapamycin (mTOR) dependent survivin expression[J].Biochemical Pharmacology,2011,(03):216-226.
  • 3Ivanov VN,Partridge MA,Johnson GE. Resveratrol sensitizes melanomas to TRAIL through modulation of antiapoptotic gene expression[J].Experimental Cell Research,2008,(06):1163-1176.
  • 4Safa AR,Day TW,Wu CH. Cellular FLICE-like inhibitory protein (C-FLIP):A novel target for cancer therapy[J].CURRENT CANCER DRUG TARGETS,2008,(01):37-46.
  • 5Bagnoli M,Canevari S,Mezzanzanica D. Cellular FLICE-inhibitory protein (c-FLIP) signalling:A key regulator of receptor-mediated apoptosis in physiologic context and in cancer[J].International Journal of Biochemistry and Cell Biology,2010,(02):210-213.
  • 6Kataoka T,Budd RC,Holler N. The caspase-8 inbibitor FLIP promotes activation of NF-κB and Erk signaling pathways[J].CURRENT BIOLOGY,2000,(05):640-648.
  • 7Krueger A,Schmitz I,Baumann S. Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase 8 activation at the CD95 death inducing signaling complex[J].Journal of Biological Chemistry,2001,(11):20633-20640.
  • 8Kinoshita H,Yoshikawa H,Shiiki K. Cisplatin (CDDP) sensitizes humanoste osarcoma cell to Fas/CD95-mediated apoptosis by down-regulating c-FLIP-L expression[J].International Journal of Cancer,2000,(06):986-991.
  • 9Leeona G,Daniel B,Longley. Chemotherapy and TRAIL mediated colon cancer cell death:The roles of p53,TRAIL receptors,and c-FLIP Mol[J].Cancer Ther,2005,(12):2026-2036.
  • 10Micheau O,Solary E,Hammann A. Fas ligand-independent,FADD mediate activation of the Fas death pathway by anticancer drugs[J].Biological Chemistry,1999,(12):7987-7992.

二级参考文献8

  • 1[1]Tormanen-Napankangas U, Soini Y, Kahlos K, et al. Expression of caspase-3, -6 and -8 and their relation to apoptosis in non-small cell lung carcinoma. Int J Cancer,2001,93(2)∶192-198.
  • 2[2]Ferreira CG, Span SW, Peters GJ, et al. Chemotherapy triggers apoptosis in a caspase-8-dependent and mitochondria-controlled manner in the non-small cell lung cancer cell line NCI-H460. Cancer Res,2000,60(24)∶7133-7141.
  • 3[3]Irmler M, Thome M, Hahne M, et al. Inhibition of death receptor signals by celluar FLIP. Nature,1997,388(6638)∶190-195.
  • 4[4]Bullani RR, Huard B, Viard-Leveugle I, et al. Selective expression of FLIP in malignant melanocytic skin lesions. J Invest Dermatol,2001,117(2)∶360-364.
  • 5[5]Sturzl M, Hohenadl C, Zietz C, et al. Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells. J Natl Cancer Inst,1999,91(20)∶1725-1733.
  • 6[6]Irisarri M, Plumas J, Bonnefoix T, et al. Resistance to CD95-mediated apoptosis through constitutive c-FLIP expression in a non-Hodgkin's lymphoma B cell line. Leukemia,2000,14(12)∶2149-2158.
  • 7[7]Ryu BK, Lee MG, Chi SG, et al. Increased expression of cFLIP(L) in colonic adenocarcinoma. J Pathol,2001,194(1)∶15-19.
  • 8[8]Frese S, Brunner T, Gugger M, et al. Enhancement of Apo2L/TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-induced apoptosis in non-small cell lung cancer cell lines by chemotherapeutic agents without correlation to the expression level of cellular protease caspase-8 inhibitory protein. J Thorac Cardiovasc Surg,2002,123(1)∶168-174.

共引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部